Reported about 15 hours ago
KKR has made a cash offer of approximately $1.22 billion for the Swedish biotechnology company Biotage, proposing a price of 145 crowns per share, which is 60.1% higher than its previous closing price. Biotage's board has unanimously recommended that shareholders accept the offer.
Source: YAHOO